MedPath

Role of local application of insulin on diabetic wound healing

Phase 4
Completed
Conditions
Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications
Registration Number
CTRI/2021/05/033671
Lead Sponsor
Kasturba Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
54
Inclusion Criteria

•Patients with diabetic ulcers (both type 1 & type 2) in lower limbs.

•Patients who are above 18 years of age

•Patients with ulcer area of <= 30cm2.

•Patients with Grade 0, 1 and Stage A, C according to University of Texas Diabetic Wound classification.

•Patients who are willing to participate in study voluntarily.

Exclusion Criteria

• Patients with Grade 2, 3 and Stage B, D according to University of Texas Diabetic wound classification.

• Patients with peripheral vascular disease as in those who have monophasic flow in ultrasound

doppler.

• Burns wounds and Pressure sores

• Patients with venous ulcers.

• Patients more than 70 years old.

• Patients on systemic steroid therapy or immune-compromised patients.

• Non compliant patients.

• Patients with GRBS <100 mg/dl before the dressing.( Safety check)

• Pregnant female patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of Topical insulin dressings over the routine saline dressings by comparing percentage reduction in the surface area of the ulcer.Timepoint: 15 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Topical insulin application on reducing the wound healing time by comparing the time taken for the ulcer to decrease in size.Timepoint: 15 days
© Copyright 2025. All Rights Reserved by MedPath